HealthTech Hub Masterclass: What are the Fundamental Aspects of Business Communications for Health Innovators?
Event description
When you start a business, mastering the fundamentals of good business communication matters. As an early founder, you know it is important, but you may not yet know how to build a website, have a social media presence and manage the public persona of the company, team and founders. So where do you start? How can you be resourceful, strategic and agile?
What You Will Learn:
In this Masterclass, our communication experts take you through:
- Why does communication matter?
- Who should you be talking to?
- What do they care about?
- Where are they active online?
- Where do they currently get industry information from?
- When are they most likely open to new business / too busy?
- How will people find you online?
- How can you spread your profile/website online?
Who Should Attend
This masterclass is designed for entrepreneurs, researchers, and professionals in the health tech sector who are looking for guidance on how to create or improve their business communications with key stakeholders, including customers, partners and investors.
Meet the Experts:
More guests to be announced
**Lunch will be provided
Cicada Innovations is proud to be collaborating with the Westmead Health & Innovation District, Australia’s
fastest-growing health and innovation precinct, for this commercialisation masterclass series. These masterclasses
are to help bridge the gap between research and commercialisation.
Find out more about the Cicada HealthTech Hub
The Cicada HealthTech Hub is proudly supported by NSW Government and is part of the Westmead’s Health & Innovation District. The district includes 4 major hospitals, 4 world-leading medical research institutes, 2 university campuses and the largest research-intensive pathology service in NSW. By 2036, the number of full-time staff will increase to more than 50,000 and the number of students will expand to more than 10,000. Among the first projects for development is a viral vector advanced manufacturing facility to provide ground-breaking trial therapies for infections, cancer and genetic diseases.